BIOSOURCE INTERNATIONAL INC
10-Q, EX-27.1, 2000-08-04
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: BIOSOURCE INTERNATIONAL INC, 10-Q, 2000-08-04
Next: CORPORATE OFFICE PROPERTIES TRUST, 10-Q, 2000-08-04



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           2,503
<SECURITIES>                                         0
<RECEIVABLES>                                    6,738
<ALLOWANCES>                                       239
<INVENTORY>                                      6,619
<CURRENT-ASSETS>                                18,436
<PP&E>                                           9,252
<DEPRECIATION>                                   3,795
<TOTAL-ASSETS>                                  40,212
<CURRENT-LIABILITIES>                            4,856
<BONDS>                                              0
                                0
                                      6,405
<COMMON>                                             8
<OTHER-SE>                                      27,748
<TOTAL-LIABILITY-AND-EQUITY>                    40,212
<SALES>                                         16,340
<TOTAL-REVENUES>                                16,340
<CGS>                                            6,316
<TOTAL-COSTS>                                    7,768
<OTHER-EXPENSES>                                  (94)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 193
<INCOME-PRETAX>                                  2,158
<INCOME-TAX>                                       669
<INCOME-CONTINUING>                              1,489
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,489
<EPS-BASIC>                                       0.00
<EPS-DILUTED>                                     0.00


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission